In 2009, GenoMed® obtained certification for its quality management system under the NP EN ISO 9001:2008 standard and transitioned to the 2015 version in 2018.
GenoMed®’s management policy aims to continuously enhance the quality of our services and overall performance. Our primary goal is to promote the satisfaction of the needs and expectations of customers and employees following the principles of quality management, NP EN ISO 9001:2015, and complying with all relevant legislation related to our activity.
Specialized molecular diagnostic services
External Quality Assessment
In order to ensure the quality of the results obtained, GenoMed® participates in external evaluation programs promoted by several international entities, such as:
- EMQN – European Molecular Quality Network
- GenQA – Genomic Quality Assessment, is a member of UK NEQAS Consortium
- UK-NEQAS – United Kingdom National External Quality Assessment Service
- GHEP-ISFG – Spanish and Portuguese Language Group of the International Forensic Genetics Society
- CAP – College of American Pathologists
Guidelines/ Recommendations
The internal quality control procedures implemented are based on guidelines and recommendations issued by prestigious international institutions and reference in their respective areas.
Some examples are:
- EMQN – Best practice guidelines;
- ACMG – Best practice guidelines (NGS);
- ACGS – Practice guidelines for Targeted Next Generation Sequencing Analysis and Interpretation;
- EuroGentest – Standards and Guidelines for clinical Genetics Laboratories – American College of Medical Genetics;
- OECD – Guidelines for quality assurance in molecular genetic testing;
- EuroGentest – Cytogenetic Guidelines and Quality Assurance;
- Association for Clinical Cytogenetics – Professional guidelines for clinical cytogenetics;
- National Comprehensive Cancer Network (NCCN) – Clinical Practice Guidelines in Oncology;
- European LeukemiaNet – Diagnosis and Management of Acute Myeloid Leukemia in adults (Recommendations from an International Expert Panel);
- European LeukemiaNet – Recommendations for the Management of Chronic Myeloid Leukemia (CML).